Neural Therapeutics Inc.
NURL
CNSX
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 46.30K | 81.90K | 119.50K | 181.90K | 377.50K |
| Total Receivables | 4.90K | 5.10K | 4.80K | 28.50K | 7.50K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.80K | 10.50K | 14.20K | 17.80K | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 1.10K |
| Total Current Assets | 53.00K | 97.50K | 138.60K | 228.20K | 386.00K |
|
|
|||||
| Total Current Assets | 53.00K | 97.50K | 138.60K | 228.20K | 386.00K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.21M | 1.41M | 138.60K | 228.20K | 386.00K |
|
|
|||||
| Total Accounts Payable | 51.10K | 8.20K | 8.40K | 26.80K | 46.20K |
| Total Accrued Expenses | 219.40K | 108.50K | 118.10K | 97.00K | 146.40K |
| Short-term Debt | -- | -- | -- | -- | 8.20K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 135.20K | 116.70K | 126.50K | 123.80K | 200.90K |
|
|
|||||
| Total Current Liabilities | 135.20K | 116.70K | 126.50K | 123.80K | 200.90K |
| Long-Term Debt | 593.20K | 552.80K | 538.10K | 533.10K | 488.30K |
| Short-term Debt | -- | -- | -- | -- | 8.20K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 728.50K | 669.50K | 664.60K | 656.90K | 689.10K |
|
|
|||||
| Common Stock & APIC | 4.04M | 3.91M | 2.63M | 2.55M | 2.04M |
| Retained Earnings | -4.14M | -3.73M | -3.73M | -3.86M | -3.01M |
| Treasury Stock & Other | 583.40K | 564.60K | 571.70K | 885.70K | 662.20K |
| Total Common Equity | 481.60K | 744.90K | -526.00K | -428.70K | -303.10K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 481.60K | 744.90K | -526.00K | -428.70K | -303.10K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 481.60K | 744.90K | -526.00K | -428.70K | -303.10K |
|
|
|||||